Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart DRC | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$948.23B | 36.2x | 1.31 | CA$35.85 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Loblaw Companies | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$61.62B | 29.1x | 3.97 | CA$205.14 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -4.9% Downside | Upgrade to Pro+ | |
George Weston 4.75 Ser V Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$31.77B | 24.7x | CA$20.80 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
George Weston Ser 3 Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$31.77B | 24.7x | -2.74 | CA$22.11 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston 5.20 Ser Iv Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$31.77B | 24.7x | -2.74 | CA$22.13 | -3.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$31.77B | 24.7x | CA$244.85 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
George Weston Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$31.77B | 24.7x | -2.74 | CA$24.35 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$31.77B | 24.7x | -2.74 | CA$244.77 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.6% Upside | Upgrade to Pro+ | |
Metro Inc. | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$22.14B | 23.5x | -10.77 | CA$100.42 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.4% Downside | Upgrade to Pro+ | |
Empire Company | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$11.21B | 17.1x | -2.33 | CA$47.92 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.3% Upside | Upgrade to Pro+ | |
North West | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$2.51B | 19.4x | 12.61 | CA$52.51 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.4% Upside | Upgrade to Pro+ | |
Green Thumb | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$1.69B | 23.8x | 0.16 | CA$7.14 | -5.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Glass House Brands | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$357.63M | -19.9x | -0.24 | CA$5.93 | -9.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Verano Holdings | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$262.03M | -0.6x | 0 | CA$0.73 | -13.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
High Tide | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$208.82M | -36.7x | -0.37 | CA$2.58 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CareRx | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$164.54M | -34.1x | -1.76 | CA$2.65 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 46.2% Upside | Upgrade to Pro+ | |
Terrascend | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$149.49M | -1.6x | -0.07 | CA$0.51 | -8.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Terrascend | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$149.49M | -1.6x | -0.07 | CA$0.51 | -8.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Colabor Group Inc. | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$94.87M | 46x | -0.81 | CA$0.93 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Planet 13 | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$81.29M | -1.5x | -0.02 | CA$0.25 | -21.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Planet 13 | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$81.29M | -1.5x | -0.02 | CA$0.25 | -21.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaCorp Rx | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$56.28M | -30x | 0.83 | CA$0.48 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marimed | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$47.06M | -3.2x | -0.1 | CA$0.12 | -20.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Two Hands | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$32.66M | 0x | -0.03 | CA$0.007 | 50% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
C21 Invest | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$23.60M | CA$0.20 | -4.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
DAVIDsTEA | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$20.08M | -1.6x | -0.08 | CA$0.70 | -9.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gold Flora | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$15.53M | -0.1x | 0 | CA$0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CordovaCann | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$13.22M | -11.6x | -0.19 | CA$0.09 | -58.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CanadaBis Capital | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$13.13M | 65.1x | -0.69 | CA$0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nass Valley Gateway | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$11.62M | -7.5x | CA$0.04 | -12.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Im Cannabis | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$6.79M | -0.5x | 0.48 | CA$2.20 | -10.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Blueberries Medical | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$4.95M | -4.7x | -0.09 | CA$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CLS Holdings USA | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$4.94M | -0.8x | -0.02 | CA$0.03 | -37.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CLS Holdings USA | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$4.94M | -0.8x | -0.02 | CA$0.03 | -37.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rocky Mountain Liquor | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$4.78M | -11x | 0.07 | CA$0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ORAGIN Foods | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$3.12M | -1x | CA$0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Entourage Health | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$1.54M | -0.1x | -0 | CA$0.005 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Astron Connect | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$756.78K | -4.9x | -0.1 | CA$0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kiaro Holdings | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$221.07K | -0x | CA$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |